Fasting Blood Glucose and Glycemic Control

Fasting blood glucose is the concentration of glucose in plasma or blood measured after an overnight fast, when the influence of recent food intake has cleared. It is the most basic single measurement of glucose homeostasis and a reference point for describing glycemic control.

Definition

Fasting blood glucose is the plasma (or whole-blood) glucose concentration measured after a defined period without caloric intake, reflecting hepatic glucose output balanced against basal insulin-mediated uptake in the post-absorptive state.

Scope

The entry covers what the fasting glucose measurement represents biochemically, how the analyte is measured and how pre-analytical factors affect it, and how it sits among other glycemic markers. It is a reference-biochemistry topic and does not state diagnostic cut-points for, or management of, any individual.

Core questions

• What physiological balance does the fasting glucose value reflect?
• Which pre-analytical and analytical factors influence a measured fasting glucose result?
• How does fasting glucose complement time-integrated markers such as glycated hemoglobin?

Key concepts

• Post-absorptive (fasting) state
• Hepatic glucose output
• Basal insulin action
• Plasma versus whole-blood glucose
• Glycolysis in the sample tube (pre-analytical loss)
• Glucose oxidase and hexokinase assay methods

Mechanisms

In the fasting state, blood glucose is sustained mainly by hepatic glycogenolysis and gluconeogenesis, opposed by basal insulin secretion that restrains glucose output and promotes peripheral uptake; the resulting steady-state concentration is what the fasting measurement captures. Analytically, glucose is most commonly measured by enzymatic methods (hexokinase or glucose oxidase). A key pre-analytical caveat is that glycolysis by blood cells continues after sampling and lowers glucose unless collection tubes contain an effective inhibitor, so handling conditions materially affect the result (Sacks et al., 2011; Burtis et al., 2012).

Clinical relevance

Fasting glucose is one of the oldest and most widely used markers of glucose regulation and underlies how impaired fasting glucose and diabetes are described in laboratory guidelines. This entry explains what the value means and how it is measured; it does not provide diagnostic thresholds or treatment guidance for individuals, which are set by current clinical guidelines applied by clinicians.

Epidemiology

Because it is inexpensive and widely available, fasting glucose has historically been a primary screening analyte for disorders of glucose regulation in population settings, with results dependent on standardized, traceable assays (Sacks et al., 2011).

History

Quantitative blood-sugar measurement emerged in early twentieth-century clinical chemistry, evolving from reducing-sugar methods to specific enzymatic assays. Standardization efforts and laboratory consensus guidelines later harmonized how fasting glucose is collected, measured, and reported (Sacks et al., 2011).

Debates

How should pre-analytical glycolysis be controlled?

Continued glycolysis in the collection tube can lower measured glucose before analysis; the adequacy of sodium fluoride versus rapid separation or citrate-based tubes for inhibiting this loss has been a recurring laboratory-medicine discussion.

Seminal works

• sacks-2011
• ada-standards-2024

Frequently asked questions

Why must a glucose sample be handled carefully before testing?

Blood cells keep metabolizing glucose after the sample is drawn, which can lower the measured value over time unless the tube contains an effective glycolysis inhibitor or the plasma is separated quickly.

How does fasting glucose differ from glycated hemoglobin?

Fasting glucose is a single snapshot of the post-absorptive state, whereas glycated hemoglobin reflects average glucose exposure over the preceding weeks to months.